Association for the Advancement of Blood & Biotherapies Annual Meeting On-Demand 2023

60 $

+ Include: 101 videos, size: 40.5 GB

+ Target Audience: hematologist


+ Include: 101 videos, size: 40.5 GB

+ Target Audience: hematologist

+ Sample video: contact me for sample video

+ Information:

The AABB Annual Meeting brings together the latest research and practice-changing resources for the fields of blood and biotherapies. Colleagues from throughout the world attend to connect, network, learn and advance the field.

The Association for the Advancement of Blood & Biotherapies (AABB) hosted its 2023 Annual Meeting On-Demand from October 14 to October 17, 2023. Here are some key details about the event:

Content and Topics:

  • The meeting covered cutting-edge research, unique perspectives, and practice-changing solutions in the fields of transfusion medicine, blood banking, and biotherapies

Education Sessions:

  • The AABB Annual Meeting is renowned for providing top-quality education sessions. These sessions cover new and innovative topics, allowing professionals to stay informed and earn continuing education credits


+ Topics:

2023 AABB RBC Transfusion Guidelines Debate Which Restrictive Hemoglobin Threshold.ts
2023 Emily Cooley Memorial Award and Lectureship.ts
2023 Hemphill-Jordan Leadership Award and Lectureship.ts
2023 Tibor Greenwalt Memorial Award and Lectureship.ts
A Quality Toolkit to Aid in Conformance to AABB Standard 5.0.ts
Armed Services Blood Program Readiness in the Present with a Focus on the Future.ts
ASHI AABB Joint Session The Problem with Platelets How Perspectives of Various Practitioners Involved in Platelet Support of Refractory Patients Has Led to Continuing Controversies.ts
Ask the FDA and CMS CLIA.ts
Ask the Standards.ts
Autoimmune Hemolytic Anemias Updates in Diagnoses, Clinical Care and Translational Science.ts
Better Together Serology and Genomics to Resolve Red Blood Cell and Platelet Antibody Cases.ts
Biotherapies Abstract Spotlight.ts
Biotherapies for Targeting Unwanted Alloantibodies in Transfusion Medicine.ts
Blood Bank Guy Essentials LIVE.ts
Blood Group Genotyping and Interpretation of Variant RBC Antigens Using Bioinformatic Tools.ts
Cellular Starting Material (CSM) Forum.ts
CEO Panel Abstract Spotlight.ts
Challenges in Pediatric Apheresis Big Challenges for Small Patients.ts
Challenging Antibody Investigations in the Immunohematology Reference Lab.ts
Civilian Walking Blood Banks Considerations for Crisis Readiness and Settings Where Banked Blood is Unavailable.ts
Clinical Centers as Partners in Advanced Cell and Gene Therapy Manufacturing – Roles, Challenges & Future Considerations.ts
Coverage and Reimbursement Policy for Transfusion Medicine and Cellular Therapies What U.S. Hospitals Need to Know.ts
Creative Solutions for Apheresis Supply Chain Challenges.ts
Critical Role of Analytics Analytical Development for Cell and Gene Therapy Product Acceptance and Licensure.ts
Cultivating Emotional Intelligence A Guide for Emerging Leaders – Presentation and Round Table Discussion.ts
Deciphering the Clinical Clues Updates to Protocols and Procedures for Anti-CD47 Agents in Clinical Laboratories.ts
Defining the Benefits of Blood Collector-Sponsored Efforts to Improve Donor and Community Health.ts
DEI – The Leader’s Role in Building and Sustaining a DEI Culture Through Staff Engagement.ts
Designing and Optimizing Massive Hemorrhage Protocols.ts
Directed Donations and COVID-19 Unvaccinated Donors Ethical Framework and Practical Considerations.ts
Driver’s Ed Using Audits to Drive Process Improvement.ts
Effects of Blood Donor Social Behaviors on the Quality and Efficacy of Red Blood Cell Transfusions.ts
Equity in Healthcare Panel Discussion.ts
Expecting the Unexpected How Transfusion Services Can Effectively Prepare for Unexpected Information System Downtimes.ts
Exploring the Dynamics of Hospital Blood Ordering Behaviors Standardized Hospital and Blood Supplier Communication As Key To Inventory Management.ts
Eyedrops of Human Origin (EDHO) Guidelines for Production, Clinical Use and Regulation.ts
Go for GOLD A Critical Need for a New GOLD Standard for Blood Cell Recovery and Survival Studies.ts
Hope in Blood Outpatient Transfusions in the Hospice Patient Population.ts
HOT TOPIC – Individual Donor Assessment.ts
How Does the FDA Use Real World Data and Real World Evidence.ts
How to Build a Pre-Hospital Transfusion Program Between Emergency Medical Services and a Hospital-Based Transfusion Service Versus a Blood Center.ts
Hyperhemolysis Syndrome Recognition and Current Management Strategies of a Potentially Fatal Transfusion Complication.ts
Impact of Hospital Mergers and Acquisitions on the Transfusion Service.ts
Impacting Hemovigilance and Patient Safety with a National Alloantibody Exchange.ts
Implicit Bias in the Workforce and Healthcare.ts
Inspection Findings and Updates from FDA’s Office of Regulatory Affairs Where Does Your Institution Rank Regarding the Most Cited Deficiencies.ts
Intrauterine Transfusions Transfusing the Tiniest, Is It The Trickiest.ts
Landsteiner Alter Award.ts
Leadership and Personal Development Tools to Unlearn Unconscious Bias (workshop).ts
Lean is the Enemy of Preparedness Analysis of Contribution of Supply Chain Shortages Affecting Blood Supply for Transfusion Medicine.ts
Management of IgA-Deficient Blood Products and Patients An Ongoing Challenge.ts
Managing the Media Tools to Communicate with the Public Effectively.ts
Massive Transfusion Protocols in Pediatric Patients.ts
Moving Beyond the Label – How the MPHO Unique Identifier Improves Traceability and Enhances Biovigilance.ts
Navigating the FDA Licensure Pathway.ts
New Insights into the Development and Consequences of RBC Alloimmunization.ts
New Plasma & Platelet Transfusion Guidance for Critically Ill Children by Transfusion Anemia Expert Initiative Control Avoidance of Bleeding, TAXI-CAB.ts
Novel Data Science Techniques in Transfusion Medicine and Cell Therapy State-of-the-Art and Future Direction.ts
Novel Frontiers in Biotherapies Exosomes (inclusive of Extracellular Vesicles) and Cytokines.ts
Optimizing Apheresis Collections to Enable Hematopoietic Stem Cell Gene Therapies.ts
Oral Abstract – Arboviruses & Parasites.ts
Oral Abstract – Blood Components & Apheresis.ts
Oral Abstract – Coagulation & Immunology.ts
Oral Abstract – COVID-19 Seroepidemiology.ts
Oral Abstract – Emerging Blood & Biotherapy Products.ts
Oral Abstract – Infectious Risk & Donor Policy.ts
Oral Abstract – Informatics & Innovation.ts
Oral Abstract – Mouse Models.ts
Oral Abstract – Novel Alleles.ts
Oral Abstract – Patient Blood Management.ts
Oral Abstract – Platelets.ts
Oral Abstract – Practical Immunohematology.ts
Oral Abstract – RBC Component Quality.ts
Oral Abstract – Transfusion Service.ts
Oral Abstract Blood Donor.ts
Pathogen Reduced Cryoprecipitate Early Experiences and Inventory Management Outcomes.ts
Perfusion, Not Transfusion Providing Blood Products for Organ Perfusion Before Transplantation.ts
Platelet Refractoriness Management – How to Treat Refractory Patients When Nothing Else Works.ts
Plenary Oral Abstract.ts
Potential Role of Intravenous Hemostatic Agents Adjuncts in Pediatric Trauma A Review of the Evidence for (or Against) Their Use.ts
Present Day Blood Banking Trials and Tribulations; Staffing Challenges.ts
REDS Abstract Spotlight.ts
Release Criteria for Cellular Therapy Products (CTPs) Prior to Distribution Practical Advices That You Need to Know.ts
Sally Frank Award.ts
Standardization of Post-Thaw Viability Testing Method for Cryopreserved Hematopoietic Progenitor Cells.ts
Test Your BB Knowledge.ts
The Approach to Bleeding in Patients Receiving Targeted Factor XI Therapy.ts
The BLOODSAFE Program Building the Future of Access to Safe Blood in Sub-Saharan Africa.ts
The Dawn of a New Age Individual Donor Assessment.ts
The Next Frontier Further Cellular Therapy Manufacturing with ISBT 128 Chain of Identity Identifier.ts
The Road Not Taken Data-Driven Reasons to Decline a Request for Therapeutic Apheresis.ts
The Science.or Not Behind Deferrals of Blood Donors With a History of Cancer.ts
The Unextinct Dinosaurs, Whole Blood in Civilian Transfusion Practice.ts
THOR AABB Prehospital Transfusion The Latest Evidence and Expert Discussion.ts
Transfusion Transmissible Infections Monitoring System (TTIMS) Tools to Assess the Safety of the Blood Supply Over Time.ts
Untangling the Advanced Therapies Landscape Positioning the Community Blood Center for Success.ts
Use of Apheresis Modalities for the Management of Solid Organ Transplant Rejection.ts
Using Simulation to Train Nurses and Residents in Therapeutic Apheresis Complications.ts
Weak RhD Phenotypes and RHD Genotyping Who, What, When, Where, Ho.ts
Wizardry School of Antigens and Antibodies.ts
Workforce Development in Cell Processing Labs A Comprehensive Approach to Skills Enhancement and Employee Retention.ts


There are no reviews yet.

Be the first to review “Association for the Advancement of Blood & Biotherapies Annual Meeting On-Demand 2023”

Your email address will not be published. Required fields are marked *